Hironao Okubo

4PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 27, 2026
Nivolumab Plus Ipilimumab for Unresectable Hepatocellular Carcinoma in Early Real-World Clinical Practice: A Multicenter Analysis of Efficacy and Safety.

|Feb 16, 2026
A case of complete remission with durvalumab-cabozantinib sequential therapy for advanced hepatocellular carcinoma.

Masaki Ogami, Hironao Okubo, Ryuji Yoshioka

|Jan 31, 2026
Guidance for Liver Rehabilitation in Chronic Liver Disease.

Shuji Terai, Hiroteru Kamimura, Yoichi Hiasa

|Sep 24, 2024
Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification.

Hironao Okubo, Hitoshi Ando, Shunsuke Nakamura

Pageof 1

Frequent Collaborators

1 joint publications

Shuji Terai

1 joint publications

Yoichi Hiasa

1 joint publications

Toru Ishikawa

1 joint publications

Yuichiro Eguchi